The Department of Justice on Wednesday accused drug maker Regeneron Pharmaceuticals Inc. of fraudulent practices related the pricing of its blockbuster Read this story
The Department of Justice on Wednesday accused drug maker Regeneron Pharmaceuticals Inc. of fraudulent practices related the pricing of its blockbuster Read this story
More from Marketwatch | article_normal Biotechnology Services Pharmaceuticals Insurance Non-life Insurance Health Medical Insurance Healthcare Life Sciences Biopharmaceuticals Financial Services Government Sponsored Health Insurance Corporate Crime Legal Action Regulation Government Policy Financial Performance Earnings Sales Figures Corporate Industrial News Political General News Crime Fraud Content Types Factiva Filters C&E Executive News Filter C&E Industry News Filter Regeneron Pharmaceuticals Inc. REGN corporate crime legal action regulation government policy financial performance earnings sales figures corporate industrial news political general news crime fraud content types factiva filters c&e executive news filter c&e industry news filter biotechnology services pharmaceuticals insurance non-life insurance health medical insurance healthcare life sciences biopharmaceuticals financial services government sponsored health insurance